Proteoglycans contribute to the functional integrity of the glomerular endothelial cell surface layer and are regulated in diabetic kidney disease.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
19 04 2021
Historique:
received: 20 11 2020
accepted: 01 04 2021
entrez: 20 4 2021
pubmed: 21 4 2021
medline: 9 11 2021
Statut: epublish

Résumé

All capillary endothelia, including those of the glomeruli, have a luminal cell surface layer (ESL) consisting of glycoproteins, glycolipids, proteoglycans (PGs) and glycosaminoglycans. Previous results have demonstrated that an intact ESL is necessary for a normal filtration barrier and damage to the ESL coupled to proteinuria is seen for example in diabetic kidney disease (DKD). We used the principles of ion exchange chromatography in vivo to elute the highly negatively charged components of the ESL with a 1 M NaCl solution in rats. Ultrastructural morphology and renal function were analyzed and 17 PGs and hyaluronan were identified in the ESL. The high salt solution reduced the glomerular ESL thickness, led to albuminuria and reduced GFR. To assess the relevance of ESL in renal disease the expression of PGs in glomeruli from DKD patients in a next generation sequencing cohort was investigated. We found that seven of the homologues of the PGs identified in the ESL from rats were differently regulated in patients with DKD compared to healthy subjects. The results show that proteoglycans and glycosaminoglycans are essential components of the ESL, maintaining the permselective properties of the glomerular barrier and thus preventing proteinuria.

Identifiants

pubmed: 33875683
doi: 10.1038/s41598-021-87753-3
pii: 10.1038/s41598-021-87753-3
pmc: PMC8055884
doi:

Substances chimiques

Proteoglycans 0
Sodium Chloride 451W47IQ8X

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8487

Références

Am J Physiol Renal Physiol. 2007 Jun;292(6):F1802-9
pubmed: 17376766
Diabetes. 2011 Sep;60(9):2354-69
pubmed: 21752957
Microvasc Res. 2004 Jan;67(1):9-17
pubmed: 14709398
Diabetes. 2006 Apr;55(4):1127-32
pubmed: 16567538
J Cell Biol. 1998 Jun 1;141(5):1277-86
pubmed: 9606218
Nat Rev Cancer. 2004 Jul;4(7):528-39
pubmed: 15229478
J Am Soc Nephrol. 2009 Jan;20(1):114-22
pubmed: 19073829
Pflugers Arch. 2000 Sep;440(5):653-66
pubmed: 11007304
Kidney Int. 2011 Jun;79(12):1322-30
pubmed: 21412215
Proteomics Clin Appl. 2010 Jul;4(6-7):644-53
pubmed: 21137083
Chem Rev. 2018 Sep 26;118(18):9152-9232
pubmed: 30204432
Nephrol Dial Transplant. 2020 Dec 4;35(12):2059-2072
pubmed: 32853351
Diabetologia. 1993 Mar;36(3):244-51
pubmed: 8462774
J Am Soc Nephrol. 2007 Nov;18(11):2885-93
pubmed: 17942961
J Invest Dermatol. 1992 Dec;99(6):886-91
pubmed: 1281868
Acta Physiol Scand. 1998 May;163(1):83-91
pubmed: 9648626
Physiol Rev. 2008 Apr;88(2):451-87
pubmed: 18391170
BMC Bioinformatics. 2017 Mar 2;18(1):142
pubmed: 28249561
Biochim Biophys Acta. 1998 Apr 28;1406(3):237-50
pubmed: 9630651
J Am Soc Nephrol. 2003 Jul;14(7):1756-65
pubmed: 12819235
Diabetologia. 2006 Sep;49(9):2200-9
pubmed: 16868749
Am J Physiol Renal Physiol. 2005 Apr;288(4):F748-56
pubmed: 15585670
FASEB J. 2001 Mar;15(3):559-61
pubmed: 11259366
Am J Physiol Renal Physiol. 2015 Feb 15;308(4):F287-97
pubmed: 25411387
PLoS One. 2011 Apr 06;6(4):e18575
pubmed: 21494642
J Am Soc Nephrol. 2019 Oct;30(10):1886-1897
pubmed: 31308073
Am J Pathol. 2020 Apr;190(4):742-751
pubmed: 32035881
PLoS One. 2010 Dec 08;5(12):e14262
pubmed: 21170388
Am J Pathol. 2013 May;182(5):1532-40
pubmed: 23518410
Diabetes. 2016 Sep;65(9):2742-53
pubmed: 27246914
Matrix Biol. 2015 Mar;42:11-55
pubmed: 25701227
Kidney Int. 2000 Feb;57(2):487-98
pubmed: 10652025

Auteurs

Alina Khramova (A)

Institute of Neuroscience and Physiology, Department of Physiology, Sahlgrenska Academy, University of Gothenburg, Box 432, 40530, Gothenburg, Sweden.

Roberto Boi (R)

Institute of Neuroscience and Physiology, Department of Physiology, Sahlgrenska Academy, University of Gothenburg, Box 432, 40530, Gothenburg, Sweden.

Vincent Fridén (V)

Institute of Neuroscience and Physiology, Department of Physiology, Sahlgrenska Academy, University of Gothenburg, Box 432, 40530, Gothenburg, Sweden.

Anna Björnson Granqvist (AB)

Institute of Neuroscience and Physiology, Department of Physiology, Sahlgrenska Academy, University of Gothenburg, Box 432, 40530, Gothenburg, Sweden.
Bioscience Renal, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.

Ulf Nilsson (U)

Institute of Neuroscience and Physiology, Department of Physiology, Sahlgrenska Academy, University of Gothenburg, Box 432, 40530, Gothenburg, Sweden.

Olav Tenstad (O)

Department of Biomedicine, University of Bergen, Bergen, Norway.

Eystein Oveland (E)

Department of Biomedicine, University of Bergen, Bergen, Norway.

Börje Haraldsson (B)

Institute of Neuroscience and Physiology, Department of Physiology, Sahlgrenska Academy, University of Gothenburg, Box 432, 40530, Gothenburg, Sweden.

Kerstin Ebefors (K)

Institute of Neuroscience and Physiology, Department of Physiology, Sahlgrenska Academy, University of Gothenburg, Box 432, 40530, Gothenburg, Sweden.

Jenny Nyström (J)

Institute of Neuroscience and Physiology, Department of Physiology, Sahlgrenska Academy, University of Gothenburg, Box 432, 40530, Gothenburg, Sweden. jenny.nystrom@gu.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH